|
Mean values (CI) for S-SECEL scores before treatment (baseline) and follow-up and p-values and effect sizes for changes at follow-up compared to baseline |
||||||
| Base, n = 100 |
1 mo, n = 95 |
2 mo, n = 86 |
3 mo, n = 81 |
6 mo, n = 75 |
12 mo, n = 71 |
|
|
|
||||||
| S-SECEL |
||||||
| Total* |
25.2 (22.5–28.0) |
30.6 (27.3–33.8) |
25.6 (21.6–29.6) |
20.6 (17.2–24.1) |
19.5 (15.3–23.7) |
15.4 (11.9–18.9) |
| p†/ES‡ |
0.00/0.34 |
ns/0.03 |
0.02/0.24 |
0.00/0.32 |
0.00/0.62 |
|
| Environment* |
14.4 (12.8–16.0) |
18.1 (16.2–19.9) |
14.9 (12.8–17.0) |
12.4 (10.4–14.4) |
11.0 (8.9–13.1) |
8.7 (6.8–10.5) |
| p†/ES‡ |
0.00/0.41 |
ns/0.04 |
ns/0.20 |
0.00/0.35 |
0.00/0.62 |
|
| Attitudinal* |
5.9 (4.7–7.1) |
8.4 (6.6–10.2) |
6.7 (5.0–8.4) |
4.9 (3.6–6.1) |
4.9 (3.0–6.8) |
3.7 (2.1–5.3) |
| p†/ES‡ |
0.00/0.29 |
ns/0.09 |
ns/0.10 |
0.50/0.11 |
0.00/0.32 |
|
| General* |
5.0 (4.5–5.4) |
5.2 (4.1–6.2) |
4.1 (3.5–4.6) |
3.4 (2.9–3.9) |
3.6 (3.0–4.1) |
3.1 (2.5–3.7) |
| p†/ES‡ |
ns/0.05 |
0.05/0.25 |
0.00/0.55 |
0.00/0.53 |
0.00/0.58 |
|
|
†p-value significant at ≤ 0.05, ns = non significant *Min-max subscales: 0–15 (general), 0–42 (environmental), 0–45 (attitudinal), and 0–102 (total) ‡Effect size (ES) of change was calculated as mean change from baseline divided by the standard deviation of change. Criteria: trivial 0 to < 0.20; small 0.20 to < 0.50; moderate 0.50 to < 0.80; and large ≥ 0.80 | ||||||
Johansson et al. BMC Cancer 2008 8:80 doi:10.1186/1471-2407-8-80 |
||||||